EUR 2.36
(-0.84%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 3.33 Million EUR | -7.28% |
2022 | 3.56 Million EUR | -6.84% |
2021 | 3.82 Million EUR | 35.57% |
2020 | 2.82 Million EUR | 4.15% |
2019 | 2.7 Million EUR | 11.63% |
2018 | 2.42 Million EUR | 18.18% |
2017 | 2.05 Million EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 2.55 Million EUR | 0.0% |
2023 Q4 | 1.08 Million EUR | 0.0% |
2023 FY | 3.3 Million EUR | -7.28% |
2023 Q2 | 1.59 Million EUR | 0.0% |
2022 FY | 3.56 Million EUR | -6.84% |
2022 Q2 | 2.12 Million EUR | 0.0% |
2022 Q4 | 1.43 Million EUR | 0.0% |
2021 Q2 | 1.69 Million EUR | 0.0% |
2021 FY | 3.82 Million EUR | 35.57% |
2021 Q4 | 2.13 Million EUR | 0.0% |
2020 Q4 | 1.31 Million EUR | 0.0% |
2020 Q2 | 1.5 Million EUR | 0.0% |
2020 FY | 2.82 Million EUR | 4.15% |
2019 Q3 | 971.97 Thousand EUR | -37.85% |
2019 FY | 2.7 Million EUR | 11.63% |
2019 Q4 | 1.17 Million EUR | 20.42% |
2019 Q2 | 1.56 Million EUR | 0.0% |
2018 Q4 | 1.36 Million EUR | 0.0% |
2018 FY | 2.42 Million EUR | 18.18% |
2018 Q2 | 1.08 Million EUR | 0.0% |
2017 FY | 2.05 Million EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Philogen S.p.A. | 23.13 Million EUR | 85.576% |
Ulisse Biomed S.p.A. | 66.2 Thousand EUR | -4939.086% |